arrow
D

Deidre Wilkins

AstraZeneca
H指数:22
被引数:1,469

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Lower Respiratory Tract Infections Following Respiratory Syncytial Virus Monoclonal Antibody Nirsevimab Immunization Versus Placebo: Analysis From a Phase 3 Randomized Clinical Trial (MELODY)

呼吸道合胞病毒单克隆抗体Nirsevimab预防接种与安慰剂后的下呼吸道感染: 一项3期随机临床试验 (MELODY) 的分析

2024-12-041
OAAI
The genomic evolutionary dynamics and global circulation patterns of respiratory syncytial virus

呼吸道合胞病毒的基因组进化动力学和全球流通模式

2024-04-104
OAAI
Molecular and phenotypic characteristics of RSV infections in infants during two nirsevimab randomized clinical trials (Vol 14, 4347, 2023)
2024-04-080
OAAI
Molecular and phenotypic characteristics of RSV infections in infants during two nirsevimab randomized clinical trials

两项nirsevimab随机临床试验中婴儿RSV感染的分子和表型特征

2023-07-1922
OAAI
Nirsevimab binding-site conservation in respiratory syncytial virus fusion glycoprotein worldwide between 1956 and 2021: an analysis of observational study sequencing data
2023-07-0135
PRE
Robust humoral and cellular recall responses to AZD1222 attenuate breakthrough SARS-CoV-2 infection compared to unvaccinated
2023-01-139
OAAI
Tolerability and immunogenicity of an intranasally- administered adenovirus-vectored COVID-19 vaccine: An open-label partially-randomised ascending dose phase I trial
2022-11-0182
OAAI
Global molecular diversity of RSV - the INFORM RSV study
2020-06-2621
OAAI